IDVYNSO
Doravirine, Islatravir
- Strength
- 100 mg/1, .25 mg/1
- Form
- Tablet, Film Coated
- Class
- Human Immunodeficiency Virus 1 Non-Nucl…
Merck Sharp & Dohme LLC
Not stocked by us — reference only
doravirine, lamivudine, and tenofovir disoproxil fumarate
Listed by Merck Sharp & Dohme LLC
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0006-5007 |
| FDA application | NDA210807 |
| RxNorm concept | 2055813 |
| Package sizes listed | 1 |
| Marketed since | July 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Doravirine, Islatravir
Merck Sharp & Dohme LLC
Not stocked by us — reference only
doravirine
Merck Sharp & Dohme LLC
Not stocked by us — reference only
doravirine
A-S Medication Solutions
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.